About this Research Topic
The management of elderly patients with lymphoma involves addressing several key issues. Those patients may have reduced physiological reserves, and multiple comorbidities and are more susceptible to treatment-related complications. Tailored treatments for age-related factors are crucial in order to achieve efficacy and limit the toxicities.
The use of comprehensive geriatric assessments to evaluate overall health, functional capacity, and cognitive status can guide treatment decisions and assess treatment tolerability. Tailoring supportive care measures is useful to meet the specific needs of elderly patients, including managing treatment side effects and addressing quality of life concerns.
Elderly patients' participation in clinical trials must be encouraged to improve treatment options and outcomes for this population. Access to multidisciplinary teams with expertise in geriatric oncology to provide comprehensive care and optimize treatment decisions is necessary.
Submitted papers should critically analyze studies, discuss any controversies or conflicting evidence, and provide a synthesis of the current state of knowledge in this specific area. Moreover, they should contribute to the understanding of lymphoma in elderly patients, provide insights for clinicians to optimize their approach to diagnosis and treatment, and guide researchers in identifying areas that require further investigation.
In this Research Topic, we aim to focus on lymphoma diagnosis in elderly patients. We welcome comprehensive examinations of the existing literature, Original Research, and Clinical Trials that cover the epidemiology and demographics of lymphoma in elderly patients.
Please note: manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent clinical or patient cohort, or biological validation in vitro or in vivo, which are not based on public databases) are not suitable for publication in this journal.
The use of comprehensive geriatric assessments to evaluate overall health, functional capacity, and cognitive status can guide treatment decisions and assess treatment tolerability. Tailoring supportive care measures is useful to meet the specific needs of elderly patients, including managing treatment side effects and addressing quality of life concerns.
Elderly patients' participation in clinical trials must be encouraged to improve treatment options and outcomes for this population. Access to multidisciplinary teams with expertise in geriatric oncology to provide comprehensive care and optimize treatment decisions is necessary.
Submitted papers should critically analyze studies, discuss any controversies or conflicting evidence, and provide a synthesis of the current state of knowledge in this specific area. Moreover, they should contribute to the understanding of lymphoma in elderly patients, provide insights for clinicians to optimize their approach to diagnosis and treatment, and guide researchers in identifying areas that require further investigation.
In this Research Topic, we aim to focus on lymphoma diagnosis in elderly patients. We welcome comprehensive examinations of the existing literature, Original Research, and Clinical Trials that cover the epidemiology and demographics of lymphoma in elderly patients.
Please note: manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent clinical or patient cohort, or biological validation in vitro or in vivo, which are not based on public databases) are not suitable for publication in this journal.
Keywords: lymphoma treatment, drug toxicities, pronostic factors, new treatment approaches, celular therapy, survival, quality of life
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
